Ribonuclease (RNase) Activity as a Marker to Predict Ovarian Tumors

Thualfeqar Al-Mohanna
Thualfeqar Al-Mohanna * § PhD Candidate at Mississippi State University
§ University of Kufa / College of Medicine

Send Message

To: Author

Ribonuclease (RNase) Activity as a Marker to Predict Ovarian Tumors

Article Fingerprint

ReserarchID

MRTV075

Ribonuclease (RNase) Activity as a Marker to Predict Ovarian Tumors Banner

Key Research Insights

Synthesized scholarly intelligence & interactive research assistant
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
Reading Preferences
Font Size
Line Spacing
Background

References

30 Cites in Article
  1. U Arnold (2008). Aspects of the Cytotoxic Action of Ribonucleases.
  2. Ulrich Arnold,Cindy Schulenburg,Doreen Schmidt,Renate Ulbrich-Hofmann (2006). Contribution of Structural Peculiarities of Onconase to Its High Stability and Folding Kinetics.
  3. U Arnold,R Ulbrich-Hofmann (2006). Natural and engineered ribonucleases as potential cancer therapiies.
  4. Burtis A Et (1999). Tietz tex book of clinical chemistry.
  5. A Benito,M Ribo,M Vilanova (2005). On the track of antitumor ribonucleases.
  6. R Cotran,V Kumar,S Robbins (1994). Robbins Pathologic Basis of Disease.
  7. L Tierney,J Mephee,M Papadakis (2001). S.M. Dornbusch, & C.F. Schmid A Primer of Social Statistics. Mc Graw-Hill Series in Sociology and Anthropology. New York, Toronto, London, Mc Graw-Hill Book Company, 1955, VIII p. 251 p., 35/6..
  8. Talicia Tarver (1992). Cancer Facts & Figures 2012. American Cancer Society (ACS).
  9. David Wegman (1976). Cancer Registry.
  10. Martin Michaelis,Jaroslav Cinatl,Puja Anand,Florian Rothweiler,Rouslan Kotchetkov,Andreas Deimling,Hans Doerr,Kuslima Shogen,Jindrich Cinatl (2007). Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells.
  11. S Mckenna,D Lindhout,I Kim,C Liu,V Gelev,G Wagner,J Puglisi (2007). Molecular framework for the activation of RNA-dependent protein kinase.
  12. N Ressler,E Olivero (2003). Investigation of ribonucleas isoenzye by an electrophoretic ultraviolet method.
  13. Claudia Lorenzo,Giuseppe D'alessio (2008). From ImmunoToxins to ImmunoRNases.
  14. Olga Ilinskaya,Katrin Decker,Andreas Koschinski,Florian Dreyer,Holger Repp (2002). Bacillus intermedius ribonuclease as inhibitor of cell proliferation and membrane current.
  15. M Ita,H Halicka,T Tanaka,A Kurose,B Ardelt,K Shogen,Z Darzynkiewicz (2008). Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines.
  16. A Levy,A Rottino (2001). Effect of disease states on ribonuclease concentration on body flids.
  17. T Uchida,F Egami (2009). RNase T 2 From Taka distase.
  18. Johann Holzmann,Peter Frank,Esther Löffler,Keiryn Bennett,Christopher Gerner,Walter Rossmanith (2008). RNase P without RNA: Identification and Functional Reconstitution of the Human Mitochondrial tRNA Processing Enzyme.
  19. K Reddi,J Holland (2006). Elevated serum ribonuclease in patients with pancreatic cancer..
  20. Kenn Gerdes,Susanne Christensen,Anders Løbner-Olesen (2009). Prokaryotic toxin–antitoxin stress response loci.
  21. Kay Fink,William Adams,William Skoog (1971). Serum ribonuclease in multiple myeloma.
  22. G Borzeko,I Vornovitskaia,M Belousov,G Gets,A Drel,S Shapot (1997). Unknown Title.
  23. S Fenandez,R Peracanala,L Frazier,R Liorens (2000). Unknown Title.
  24. Olga Ilinskaya,Florian Dreyer,Vladimir Mitkevich,Kevin Shaw,C Pace,Alexander Makarov (2002). Changing the net charge from negative to positive makes ribonuclease Sa cytotoxic.
  25. H Halicka,T Murakami,C Papageorgio,A Mittelman,S Mikulski,K Shogen,Z Darzynkiewicz (2000). Induction of differentiation of leukaemic (HL-60) or prostate cancer (LNCaP, JCA-1) cells potentiates apoptosis triggered by Onconase.
  26. Arthur Levy,Antonio Rottino (2000). Effect of Disease States on the Ribonuclease Concentration of Body Fluids.
  27. A W Al-Shammaree Sh (2002). Some Biochemica Aspects in women patients with benign and Malignant cervix and uterine tumors.
  28. D Smith,W Stein (1974). Methods in Enzymatic Analysis.
  29. T Umeda,T Moriyama,H Oura,Tsukadak (2009). Unknown Title.
  30. K Reddi (2000). Nature and possible origin of Human Serum ribonuclease.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Thualfeqar Al-Mohanna. . "Ribonuclease (RNase) Activity as a Marker to Predict Ovarian Tumors". Global Journal of Medical Research GJMR Volume 12 (GJMR Volume 12 Issue 10).

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmr

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR Classification NLMC Code: QU 58.7
Version of record

v1.2

Issue date
December 3, 2012

Language
English
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 6.7K
Total Downloads: 337
All Trends

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Ribonuclease (RNase) Activity as a Marker to Predict Ovarian Tumors

Thualfeqar Al-Mohanna
Thualfeqar Al-Mohanna University of Kufa / College of Medicine